Free cash flow Down for fQ3 due largely to increased equipment capex. Explained in Conf. Call that spending on ventilators was up, probably for the same reason that Viemed gave....
As many of you know, Viemed was a pioneer in the noninvasive ventilation market, resulting in a fleet with a number of aging ventilators. The recent Philips recall of these older machines has presented a unique opportunity to replace these devices and alleviate the need for future servicing. We've entered into an agreement with Philips to buy back a large number of our affected events. By leveraging substantial volume purchase discounts with manufacturers of new ventilators, we can use the proceeds from the buyback to significantly reduce the average age of our VIP fleet without negative impacts on our overall cash flows and P&L.
| $US 000’s | Revenue | ebitda - equip capex - leases | FCF / Revenue |
| Jun 24 | 63,967 | 1,466 | 2.3% |
| Mar 24 | 63,954 | 5,855 | 9.2% |
| Dec 23 | 65,363 | 6,521 | 10.0% |
| Sep 23 | 62,523 | 5,115 | 8.2% |
| Jun 23 | 60,284 | 4,779 | 7.9% |
| Mar 23 | 58,120 | 3,922 | 6.7% |
| Dec 22 | 40,815 | 3,271 | 8.0% |
| Sept 22 | 40,092 | 901 | 2.2% |
| Jun 22 | 36,692 | 2,738 | 7.5% |
| Mar 22 | 33,553 | 1,401 | 4.2% |
| Dec 21 | 29,525 | 1,551 | 5.3% |